Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia 12Myelodysplastic Syndromes 11Leukemia, Myeloid, Acute 10Multiple Myeloma 8Lymphoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Non-Hodgkin 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia, Lymphocytic, Chronic, B-Cell 4Lymphoma, Follicular 3Hodgkin Disease 3Graft vs Host Disease 3Waldenstrom Macroglobulinemia 2Neoplasms, Plasma Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Hematologic Neoplasms 2Wilms Tumor 1Testicular Neoplasms 1Shwachman-Diamond Syndrome 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1Philadelphia Chromosome 1Pathologic Complete Response 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Medulloblastoma 1

Interventions

Etoposide 2Cyclophosphamide 2prednylidene 1fialuridine 1deltacortene 1Vorinostat 1Vincristine 1Salvia hispanica seed extract 1Rituximab 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Doxorubicin 1Cytarabine 1Carmustine 1CT-P10 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoma, Primary Effusion × Bone Marrow Transplantation × Clear all
NCT04975698 2026-03-25

BMTCTN1903

National Heart, Lung, and Blood Institute (NHLBI)

Phase 2 Completed
12 enrolled
Lymphoid

Lymphoma, Primary Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡